Physician profile
Mark Neil Coreil
NPI 1477612539
$1,398,109.93
in general payments reported to CMS, 2019-2025
9 companies · $151K in 2025
The $151K reported for 2025 was more than what 99% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338K · 2020: $98K · 2021: $322K · 2022: $178K · 2023: $156K · 2024: $155K · 2025: $151K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $460K · Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $460,000.00 |
| Food and Beverage | $1,659.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $1,086,974.40 | 2019-2023 | Symetri, Damon, Spark |
| Envista Holdings Corporation | $305,773.99 | 2024-2025 | Symetri, Spark, Ultima |
| Nobel Biocare USA | $4,093.45 | 2020-2023 | Nobelactive |
| 3shape INC | $1,000.00 | 2020 | |
| Dental Monitoring Sas | $163.50 | 2025 | |
| Metrex Research, LLC | $35.30 | 2021 | |
| American Orthodontics Corporation | $34.93 | 2024-2025 | Empower-Metal, Master Series, Radiance |
| Gc America INC. | $18.83 | 2022 | |
| Align Technology, INC. | $15.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Coreil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.